Join Our Network
Pharmacy / Merchant
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
Copyright © All Samadhan - Operated by M/S. Genius Experts | All Rights Reserved
DBID
Registration ID: 176322642
Trade License: TRAD/DNCC/040904/2023
Incepta Pharmaceuticals Ltd. · Dry Powder Inhalation Capsule (DPI)
/ Piece
The information provided on All Samadhan is intended for general informational purposes only and is prepared based on our best practices. It is not a substitute for professional medical advice, diagnosis, or treatment. While we strive to keep the information accurate and up to date, we do not guarantee its completeness or accuracy. The absence of specific information or warnings about any medicine or service should not be considered as an assurance or endorsement by All Samadhan. All Samadhan shall not be held responsible for any consequences arising from the use of this information. We strongly recommend consulting a qualified healthcare professional or physician for any medical concerns, questions, or clarifications.
Mometasone Furoate is indicated for the maintenance treatment of asthma as prophylactic therapy in patients 4 years of age and older. It is not indicated for the relief of acute bronchospasm. It is not indicated in children less than 4 years of age.
Mometasone Furoate is a corticosteroid demonstrating anti-inflammatory properties. The precise mechanism of corticosteroid's action on asthma is not known. Corticosteroids have been shown to have a wide range of effects on multiple cell types (e.g. mast cells, eosinophils, neutrophils, macrophages, and lymphocytes) and mediators (e.g. histamines, eicosanoids, leukotrienes, and cytokines) involved in inflammation.
Recommended Dosages in Patients 4 Years of Age and Older.Previous Therapy: Patients ≥ 12 years who received bronchodilators alone
Recommended Starting Dose: 220 µg once daily in the evening
Highest Recommended Daily: 220 µg twice daily or as 440 µg once daily
Previous Therapy: Patients ≥ 12 years who received inhaled corticosteroids
Recommended Starting Dose: 220 µg once daily
Highest Recommended Daily: 440 µg once daily or 440 µg twice daily.
Previous Therapy: Patients ≥ 12 years who received oral corticosteroids
Recommended Starting Dose: 4400 µg once daily
Highest Recommended Daily: 440 µg once daily or 440 µg twice daily.
Ketoconazole, a strong inhibitor of cytochrome P4503A4 may increase plasma levels of Mometasone Furoate during concomitant dosing.
Generally side effects are mild like headache, viral infection, sore throat, nosebleeds and coughing. Systemic and local corticosteroid use may result few side effects like candida infection, immunosuppression, hypercorticism, adrenal suppression, growth effects, glaucoma and cataracts.
Pregnancy: There are no adequate and well-controlled studies in pregnant women. Mometasone Furoate, like other corticosteroids should be used during pregnancy only if the potential benefits justify the potential risk to the fetus.Lactation: It is not known if Mometasone Furoate is excreted in human milk. Since other corticosteroids are excreted in human milk, caution should be used when Mometasone Furoate is administered to nursing women.
Use with caution in active or inactive tuberculosis infection, herpes simplex virus infection of the eye, untreated infections affecting the body as a whole etc.
Corticosteroid, Respiratory corticosteroids
Protect from light, store in cool & dry place. Do not store above 30°C. Keep out of the reach of children. Protect from freezing. Insert the Inhalation Capsule in the Inhalation device just prior to use to protect from deterioration by moisture.